π Simple Summary
Calcium alpha-ketoglutarate (CaAKG) is a supplement form of a molecule your body already makes β a chemical called alpha-ketoglutarate (AKG) that sits at the center of how your cells turn food into energy. The reason it is exciting for aging is simple: your natural AKG levels drop by roughly 10-fold between young adulthood and old age, and when scientists fed it to mice, the animals lived longer and were frailer for a shorter stretch of their lives. In 2026, a study of over 4,000 people who track their health closely found that those taking a slow-release version of CaAKG scored about 1.8 years “biologically younger” on a DNA-based aging test. That sounds great β but here is the honest part: the human evidence is still thin, comes from one observational study with no control group, and no randomized trial has yet proven CaAKG makes people live longer. The bottom line: promising animal science and one intriguing human signal, but still a long way from proof.
The detailed breakdown continues below for those who want the full science.
Published: August 14, 2026
Evidence Tier: π₯ Silver β lifespan extension in worms and mice, plus one large observational human study showing lower biological age, but no randomized human trial yet
Category: π Supplements & Compounds
βοΈ At a Glance: Pros & Cons
β οΈ We are researchers, not doctors. Nothing on this page is medical advice. Talk to your doctor before taking CaAKG β especially if you have kidney disease, a history of kidney stones, or any active cancer. The information below is for education only.
β Pros
- Real lifespan data in mammals: CaAKG extended lifespan and compressed the frailty period in middle-aged mice (Cell Metabolism, 2020).
- Mechanism makes sense: AKG is a fuel for the enzymes that keep your DNA’s “age tags” in check β a plausible, testable theory of how it works.
- Natural and already in your body: AKG is a normal metabolite, not a foreign drug, which lowers the chance of a surprise safety problem.
- Intriguing human signal: A 2026 study of 4,260 people linked a slow-release CaAKG to 1.8 years lower biological age.
β Cons
- No randomized human trial: Every human claim so far rests on one observational study with healthy-user bias, not a controlled experiment.
- Absorption problem: Plain AKG is poorly absorbed and cleared fast, which is why the promising product uses a special slow-release form.
- Unknown long-term safety: AKG tweaks the very enzymes that regulate genes, and no one has studied high-dose use for years on end.
- Theoretical cancer question: Because AKG fuels cell growth pathways, some researchers worry it could feed existing tumors β unproven, but unresolved.
What Is Calcium Alpha-Ketoglutarate (CaAKG)?
Alpha-ketoglutarate (AKG, also called 2-oxoglutarate) is a small molecule your cells make continuously. It is a key link in the Krebs cycle β the assembly line inside your mitochondria that converts the food you eat into usable energy. But AKG is not just an energy middleman. It also does a second, less obvious job: it is the essential fuel for a family of enzymes (called dioxygenases) that remove chemical “tags” from your DNA and histones β the process that keeps your genes flexible and correctly switched on and off. That second job is exactly why AKG became a longevity story.
Calcium alpha-ketoglutarate (CaAKG) is simply AKG bound to calcium, which makes it a stable salt. The reason that matters is practical: plain AKG is absorbed poorly and flushed from the body quickly, so binding it to calcium (and, in commercial products, putting it in a delayed-release capsule) keeps more of it in your bloodstream longer. Most of the longevity research β and the one big human study β used the calcium form rather than plain AKG.
How It Works
1. The energy engine slows with age
Your mitochondria make energy less efficiently as you get older, and AKG is right in the middle of that engine. Declining AKG is both a sign of aging and, researchers think, a contributor to it. In 2014, a landmark study in the journal Nature showed that feeding AKG to tiny worms (C. elegans) extended their lifespan β and traced the effect to AKG gently slowing an energy-making protein (ATP synthase) and a growth pathway called mTOR, the same pathway rapamycin targets (Chin 2014). Mildly easing those energy and growth signals is a recurring theme in longevity: it nudges cells into a “repair and maintain” mode instead of a “grow fast” mode.
2. AKG keeps your DNA’s “age tags” in check
As you age, your DNA accumulates a specific pattern of chemical tags (methyl groups) β this is precisely what scientists measure when they estimate your “biological age” with an epigenetic clock. The enzymes that remove those tags, called TET enzymes, need AKG to work. So one proposed mechanism is straightforward: more AKG available means the TET enzymes can keep your DNA clean of age-related tags longer. This is the mechanism behind the claim that CaAKG might literally slow the aging clock (Shahmirzadi 2020; review, 2026).
3. It dials down chronic inflammation
The mouse lifespan study found that CaAKG lowered the level of inflammatory chemicals circulating in the blood and raised an anti-inflammatory signal called IL-10 (Shahmirzadi 2020). Low-grade, body-wide inflammation β scientists call it “inflammaging” β is one of the strongest drivers of age-related disease, so anything that quietens it is of interest.
The Longevity Connection
π Lifespan in Animals (The Strongest Evidence)
The animal data is why anyone talks about CaAKG at all. The 2014 Nature study found AKG extended lifespan in roundworms (Chin 2014). Then, in 2020, researchers at the Buck Institute published a study in Cell Metabolism showing that middle-aged mice fed CaAKG lived longer and β importantly β spent a shorter fraction of their lives in a frail, unhealthy state. That combination of “live longer and be frailer for less time” is what researchers call compression of morbidity, and it is the outcome everyone in longevity actually wants (Shahmirzadi 2020). Follow-up work has shown dietary AKG can also protect against muscle fibrosis in diabetic mice by restoring the same epigenetic machinery described above (2026, Metabolism).
𧬠Biological Age in Humans (Promising, but Preliminary)
In June 2026, a study published in Aging Cell analyzed 4,260 “health enthusiasts” who had bought a saliva-based epigenetic test and completed detailed supplement surveys. People taking a commercially available, slow-release CaAKG-plus-vitamin product (called Rejuvant) scored, on average, 1.8 years lower biological age than expected for their chronological age β a difference that held up after adjusting for age, sex, smoking, and health status. Interestingly, people taking regular (non-slow-release) AKG showed a much smaller, statistically insignificant benefit β which fits the absorption story (Demidenko 2026).
The honest caveats: this was a cross-sectional snapshot, not an experiment. People who buy epigenetic tests and take longevity supplements are different from the general population in many ways (the “healthy user” effect), and the authors themselves flagged that controlled trials are still needed. It is a signal worth taking seriously, but it is not proof.
𧫠Other Age-Related Outcomes (Early Stage)
Beyond lifespan, animal and lab studies point to a grab-bag of benefits: reduced inflammation, protection of muscle and bone, better fertility in female mice, and support for the immune system. A 2026 review concluded AKG “has encouraging therapeutic promise for cancer, aging, and inflammatory illnesses” β while also stressing that human clinical evidence is the missing piece (review, 2026).
Key Studies
| Study | Design | Key Finding |
|---|---|---|
| Chin et al. (2014) Nature |
C. elegans (roundworm) lifespan study | AKG extends worm lifespan by inhibiting ATP synthase and the TOR pathway β the first mechanistic clue. |
| Shahmirzadi et al. (2020) Cell Metabolism |
Mouse lifespan + healthspan study (C57BL/6) | CaAKG promoted a longer, healthier life, cut systemic inflammatory cytokines, and reduced frailty β a compression of morbidity. |
| Demidenko et al. (2026) Aging Cell |
Cross-sectional cohort, n=4,260 | Slow-release CaAKG (Rejuvant) associated with 1.8 years lower biological age; regular AKG showed no significant benefit. |
| 2026 review Biomedicines |
Narrative review | Confirms AKG’s dual role (energy + epigenetics), anti-inflammatory effects, and lifespan benefits β but flags the lack of human clinical trials. |
| 2026 study Metabolism |
Diabetic mouse model | Dietary AKG restored the Ξ±-KG/L-2HG balance and prevented muscle fibrosis by reactivating TET2 epigenetic remodeling. |
Dosing and Safety
Recommended Form
If you decide to try CaAKG, the form matters more than for most supplements:
- Calcium alpha-ketoglutarate (CaAKG) β the form used in the mouse lifespan study and the human observation. Better absorbed and longer-lasting than plain AKG.
- Delayed/slow-release CaAKG β the form linked to the 1.8-year biological-age signal in the 2026 human study (the Rejuvant product). The slow release appears to be the key difference.
- Plain AKG / arginine-AKG β cheaper, but absorbed poorly and cleared fast; the human study found no significant benefit from regular AKG.
Dosing Protocol
There is no established human dose backed by a randomized trial. This is important to say plainly. The numbers below are extrapolations from animal studies and what the observational study’s product used, not trial-validated guidance.
| Goal | Typical Daily Dose | Notes |
|---|---|---|
| General longevity interest | ~1β2 g CaAKG | The range most supplements and community protocols use, scaled from mouse data. Not trial-validated. |
| Slow-release (Rejuvant-style) | Follow product label | The proprietary blend behind the human signal. Dose is set by the manufacturer; do not double up. |
Take with or without food (food may blunt stomach upset). Because the evidence is still preliminary, treat CaAKG as an experiment you run on yourself with your doctor’s awareness β not a proven longevity pill.
Safety and Side Effects
| Concern | Details |
|---|---|
| Short-term track record | Generally well tolerated in the studies done so far; AKG is a normal body metabolite and is GRAS-listed as a food ingredient. |
| Digestive upset | The most common side effect at higher doses; taking with food or splitting the dose usually helps. |
| Calcium load | CaAKG adds calcium to your daily total β relevant if you also take calcium supplements or have kidney-stone risk. |
| Long-term safety | Unknown. No study has followed high-dose AKG use for years, and it affects the enzymes that regulate gene expression. |
| Theoretical cancer question | AKG feeds cell-growth pathways, so some researchers caution it could theoretically nourish existing tumors. Unproven, but worth a conversation with an oncologist if you have any cancer history. |
β Common Questions About Calcium Alpha-Ketoglutarate (CaAKG)
What is CaAKG and how does it work?
CaAKG is a calcium-bound form of alpha-ketoglutarate, a molecule your body makes to turn food into energy and to keep the “tags” on your DNA clean. It is thought to help with aging because your natural AKG levels fall sharply as you get older, and supplementing may support the enzymes that keep your genes healthy.
What does the evidence actually show?
The strongest evidence is in animals: AKG extended lifespan in worms and in mice, where it also reduced frailty. In humans, one 2026 study of over 4,000 people linked a slow-release CaAKG to about 1.8 years lower biological age β but that was observational, not a controlled trial, so it is promising rather than proof.
What’s the right dose?
There is no established human dose from a clinical trial. The doses people commonly use β roughly 1 to 2 grams a day of the calcium form β are extrapolated from animal studies. The slow-release product linked to the biological-age finding uses a proprietary dose, so follow its label if you take that one.
What are the risks and side effects?
The most common issue is mild digestive upset, which usually improves with food or a lower dose. Because the calcium form adds calcium to your daily intake, it may matter if you take other calcium supplements or get kidney stones. Long-term safety of high doses simply has not been studied.
Who should avoid it?
People who are pregnant or breastfeeding should avoid it because there is no safety data. Anyone with kidney disease, a history of kidney stones, or an active cancer should talk to their doctor first β the calcium content and AKG’s role in cell growth are the reasons for extra caution.
The Bottom Line
Calcium alpha-ketoglutarate sits in the interesting middle tier of longevity supplements: real lifespan data in animals, a plausible mechanism, and one intriguing but non-randomized human signal. The 2020 mouse study showing a longer life with a compressed period of frailty is exactly the kind of result that justifies attention, and the 2026 finding that slow-release CaAKG tracked with 1.8 years lower biological age is a serious data point β not hype, but also not proof.
Where it falls short is the same place most longevity supplements do: no randomized controlled trial in humans, and an absorption problem that means the form you buy matters enormously. Plain AKG barely works; slow-release CaAKG is the only form with a human signal behind it.
Our verdict: π₯ Silver. Worth watching closely and reasonable to experiment with if you use the slow-release calcium form, keep the dose modest, and go in with your doctor’s awareness β but it is not yet in the same tier as rapamycin or metformin, where the human data is far more developed. If a randomized human trial confirms the biological-age effect, CaAKG would move up the list fast.
Medical Disclaimer: This page is for educational purposes only and is not medical advice. The FDA has not evaluated these statements, and CaAKG is not approved to treat or prevent any disease. Always consult a qualified healthcare professional before starting any supplement, especially if you are pregnant, have a medical condition, or take medication. Full disclaimer β
Sources
- Chin RM, et al. “The metabolite Ξ±-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR.” Nature. 2014. PMID: 24828042
- Asadi Shahmirzadi A, et al. “Alpha-Ketoglutarate, an Endogenous Metabolite, Extends Lifespan and Compresses Morbidity in Aging Mice.” Cell Metabolism. 2020. PMID: 32877690
- Demidenko et al. “Supplements and Drugs Are Associated With Biological Age in a Cohort of Exceptionally Healthy Individuals.” Aging Cell. 2026. PMID: 42166733
- “Alpha-Ketoglutarate: A Metabolic Regulator of Cellular Homeostasis and Pathophysiology.” Biomedicines. 2026. PMID: 42072377
- “Alpha-ketoglutarate ameliorates diabetes-associated skeletal muscle fibrosis by restoring TET2-dependent epigenetic remodeling.” Metabolism. 2026. PMID: 42575166
- “Insights into the therapeutic strategies for aging and aging-associated diseases.” Signal Transduction and Targeted Therapy. 2026. PMID: 42225652